Home › NCT06802263
MIRA CONNECT Study
RecruitingHealthy volunteers welcome
Assessing Accuracy and Precision of Home Quantitative Urine Beta hCG With Serum for Pregnancy of Unknown Location (CONNECT)
Who can join
Ages 18 to 40 · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria for controls: * Non-pregnant Inclusion Criteria for cases: * Diagnosed with PUL requiring ongoing surveillance of serum hCG levels Exclusion Criteria for controls: * History of renal disease * History of type I or type II diabetes * Known malignancy of any diagnosis including hCG-secreting tumors (hepatobiliary tumors and neuroendocrine tumors) and ovarian germ cell tumors. * Gestational Trophoblastic Disease * Use of hormonal contraception within last 3 months * Patients who work the night shift Exclusion Criteria for cases: * History of renal disease * History of type I or type II diabetes * Known malignancy of any diagnosis including hCG-secreting tumors (hepatobiliary tumors and neuroendocrine tumors) and ovarian germ cell tumors. * Gestational Trophoblastic Disease * Unstable patient, concern for ruptured ectopic pregnancy * Initial serum hCG level \> 100,000 mIU/ml
About the study
The goal of this pilot study is to assess the accuracy and precision of an at-home quantitative urine beta hCG (b-hCG) test in the management of pregnancy of unknown location (PUL).
What is being tested
- at-home quantitative urine b-hCG test (diagnostic test)
Sponsor: University of Colorado, Denver · Participants: 35 · Started: Jun 1, 2024
Contact the study team
- Cara Clure, MD · Phone: 720-445-6396
- Jocelyn Phipers, NP · Phone: 303-724-7807
Official record on ClinicalTrials.gov — NCT06802263
Locations in the U.S.
| Colorado | University of Colorado, Aurora |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.